Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients.
about
From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy.Mycophenolic acid pharmacokinetics and related outcomes early after renal transplantTherapeutic drug monitoring of mycophenolic acid: does it improve patient outcome?Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients?Potential role of mycophenolate mofetil in the management of neuroblastoma patients.What is the intrapatient variability of mycophenolic acid trough levels?Effects of mycophenolate mofetil on hematocrit after renal transplantation.The need of mycophenolic acid monitoring in long-term renal transplants.Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil.Pharmacokinetics of mycophenolic acid in live donor liver transplant patients vs deceased donor liver transplant patients.Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation.Pharmacokinetic Variability of Mycophenolic Acid in Pediatric and Adult Patients With Hematopoietic Stem Cell Transplantation.
P2860
Q35666588-EC42E3BE-385C-47A4-BE0D-C99BB359A2F0Q35826828-51FACB3F-3017-4CF8-BADA-1E0DBA19C2FFQ36788423-811A236E-714E-4288-A22A-CB678DA59DB4Q38223136-E5C629C9-0AA7-4497-A892-078EFD671FD9Q40486471-F989A131-A211-483B-BB52-52E6220DBDE6Q40707992-BFDDFE85-1B0F-4DC3-9157-39902A8BAE0DQ44114552-BE750D35-DA96-42D6-BD4B-56F9BB552AB1Q45230194-57BA80FD-8AC3-4ACA-B703-7296C3DFA42EQ45289872-F7944A20-2EEE-421B-BF31-B40CF96F234CQ46623389-38455907-BAA6-4300-ADC9-24929773D21FQ46933020-6CA10AE7-2BAF-41B5-9C4F-C7DEDD200BC6Q46942520-3D24EE0C-6E2C-43E9-8A39-6B47C34F825AQ46959473-EC168FBD-F0A1-4890-B2D1-84F0775E54F9Q53126891-879D7409-D128-47DA-A4AE-D0C46BF7B402
P2860
Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Pharmacokinetics help optimizi ...... in kidney transplant patients.
@en
Pharmacokinetics help optimizi ...... in kidney transplant patients.
@nl
type
label
Pharmacokinetics help optimizi ...... in kidney transplant patients.
@en
Pharmacokinetics help optimizi ...... in kidney transplant patients.
@nl
prefLabel
Pharmacokinetics help optimizi ...... in kidney transplant patients.
@en
Pharmacokinetics help optimizi ...... in kidney transplant patients.
@nl
P2093
P2860
P1476
Pharmacokinetics help optimizi ...... in kidney transplant patients.
@en
P2093
P2860
P304
P356
10.1034/J.1399-0012.2001.150607.X
P577
2001-12-01T00:00:00Z